Literature DB >> 18216058

Impact of chronic airflow obstruction in a working population.

N Roche1, F Dalmay, T Perez, C Kuntz, A Vergnenègre, F Neukirch, J-P Giordanella, G Huchon.   

Abstract

Data on the individual and collective impact of chronic airflow obstruction at a population level are scarce. In a nationwide survey, dyspnoea, quality of life and missed working days were compared between subjects with and without spirometrically diagnosed chronic airflow obstruction. Subjects aged > or =45 yrs were recruited in French health prevention centres (n = 5,008). Results of pre-bronchodilator spirometry and questionnaires (European Community Respiratory Health Survey-derived questionnaire and European quality of life five-dimension questionnaire) were collected. Adequate datasets were available for 4,764 subjects aged 60+/-10 yrs (only 2% were aged > or =80 yrs). The prevalence of airflow obstruction (forced expiratory volume in one second/forced vital capacity of <0.70) was 7.5%. The vast majority (93.9%) of cases had not been diagnosed previously. Health status was significantly influenced by dyspnoea. Both were associated with the number of missed working days. Despite mild-to-moderate severity, subjects with chronic airflow obstruction exhibited more dyspnoea, poorer quality of life and higher numbers of missed working days (mean 6.71 versus 1.45 days.patient(-1).yr(-1) in patients without airflow obstruction, for the population with no known heart or lung disease). In conclusion, even mild-to-moderate airflow obstruction is associated with an impaired health status, which represents an additional argument in favour of early detection in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  2008        PMID: 18216058     DOI: 10.1183/09031936.00089607

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

1.  Pooled Cohort Probability Score for Subclinical Airflow Obstruction.

Authors:  Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Byron C Jaeger; Patricia A Cassano; Paulo H Chaves; David Couper; David R Jacobs; Ravi Kalhan; Robert Kaplan; Donald Lloyd-Jones; Anne B Newman; George O'Connor; Jason L Sanders; Benjamin M Smith; Yifei Sun; Jason G Umans; Wendy B White; Sachin Yende; Elizabeth C Oelsner
Journal:  Ann Am Thorac Soc       Date:  2022-08

2.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

Review 3.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

Review 4.  Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.

Authors:  Kokuvi Atsou; Christos Chouaid; Gilles Hejblum
Journal:  BMC Med       Date:  2011-01-18       Impact factor: 8.775

5.  The use of COPD maintenance therapy following spirometry in General Practice.

Authors:  Vibeke Gottlieb; Anne Marie Lyngsø; Ditte Sæbye; Anne Frølich; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2016-06-22

6.  A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol.

Authors:  Jeremy M Bunker; Helen K Reddel; Sarah M Dennis; Sandy Middleton; Cp Van Schayck; Alan J Crockett; Iqbal Hasan; Oshana Hermiz; Sanjyot Vagholkar; Guy B Marks; Nicholas A Zwar
Journal:  Implement Sci       Date:  2012-09-07       Impact factor: 7.327

7.  The French CONSTANCES population-based cohort: design, inclusion and follow-up.

Authors:  Marie Zins; Marcel Goldberg
Journal:  Eur J Epidemiol       Date:  2015-10-31       Impact factor: 8.082

Review 8.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

9.  Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population.

Authors:  Margarethe E Wacker; Matthias Hunger; Stefan Karrasch; Joachim Heinrich; Annette Peters; Holger Schulz; Rolf Holle
Journal:  BMC Pulm Med       Date:  2014-08-09       Impact factor: 3.317

Review 10.  A review of national guidelines for management of COPD in Europe.

Authors:  Marc Miravitlles; Claus Vogelmeier; Nicolas Roche; David Halpin; João Cardoso; Alexander G Chuchalin; Hannu Kankaanranta; Thomas Sandström; Paweł Śliwiński; Jaromir Zatloukal; Francesco Blasi
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.